Associate Professor, Neurology, University of California, Irvine College of Medicine
Neurology
Dr. Daniela A. Bota, MD
|
|
Give Review
Doctor Daniela A. Bota, MD works in the field of Neurology. She went to University of Kansas School of Medicine. Daniela A. Bota, MD is also a published MD. She has 29 paper published. The most recent paper is: Use of ERC-1671 Vaccine in a Patient with Recurrent Glioblastoma Multiforme after Progression during Bevacizumab Therapy: First Published Report. She is registered with Medicare and accepts Medicare payments.
Publications
- Use of ERC-1671 Vaccine in a Patient with Recurrent Glioblastoma Multiforme after Progression during Bevacizumab Therapy: First Published Report.
- Timing of surgery and bevacizumab therapy in neurosurgical patients with recurrent high grade glioma.
- Profiling Hsp90 differential expression and the molecular effects of the Hsp90 inhibitor IPI-504 in high-grade glioma models.
- Low-doses of cisplatin injure hippocampal synapses: A mechanism for 'chemo' Brain?
- TRIM11 is overexpressed in high-grade Gliomas and promotes proliferation, invasion, migration and glial tumor growth.
- Two Patients With Brain Tumors Who Received Bevacizumab and Radiotherapy: Optic Neuropathy and Quality-of-Life Issues.
- Retrospective analysis of the tolerability and activity of lacosamide in patients with Brain tumors: clinical article.
- SU-E-J-108: Quantitative Analysis of Longitudinal Cognitive Impairment Due to Radiation Therapy Based on Automatic Segmentation of Hippocampus and Subcortical Structure.
- Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy.
- Impairment of Lon-Induced Protection Against the Accumulation of Oxidized Proteins in Senescent Wi-38 Fibroblasts.
- Pulmonary metastases in patients with recurrent, treatment-resistant meningioma: prognosis and identification by ¹¹¹Indium-octreotide imaging.
- Primary leptomeningeal plasmablastic Lymphoma.
- Fos-related antigen-1 (Fra-1) is a regulator of glioma cell malignant phenotype.
- Secondary fibrosarcoma of the Brain stem treated with cyclophosphamide and Imatinib.
- Acute methotrexate neurotoxicity with choreiform movements and focal neurological deficits: a case report.
- The dynamics of insight in the prodrome of schizophrenia.
- Downregulation of the human Lon protease impairs mitochondrial structure and function and causes cell death.
- The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patients.
- Therapeutic targeting of malignant glioma.
- Antivascular endothelial growth factor antibody for treatment of glioblastoma multiforme.
- Protein degradation in mitochondria: implications for oxidative stress, aging and Disease: a novel etiological classification of mitochondrial proteolytic disorders.
- Toward a better identification and treatment of schizophrenia prodrome.
- Modulation of Lon protease activity and aconitase turnover during aging and oxidative stress.
- Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism.
- The use of patient navigators to improve Cancer care for Hispanic patients.
- Interstitial chemotherapy with biodegradable BCNU (Gliadel) wafers in the treatment of malignant Gliomas.
- Immunotherapy of Brain cancers: the past, the present, and future directions.
- Epidemiology of central Nervous system metastases.
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Ataxia
- Bell's Palsy
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Aneurysm
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Education
-
University of Kansas School of Medicine -
Carol Davila University of Medicine and Pharmacy
Hospital
-
UC Irvine Medical Center
Drug Facts
| NPI NUMBER | 1942499884 | |
| NPPES Provider LastName | BOTA | |
| NPPES Provider FirstName | DANIELA | |
| NPPES Provider ZIPCode | 928683201 | |
| NPPES Provider State | CA | |
| Specialty Description | Neurology | |
| Total Claim Count | 178.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1942499884 |
| Last Name Of The Provider | BOTA |
| First Name Of The Provider | DANIELA |
| View All |
Similar Doctors
|
|
Dr. Glenn W. Fowler, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amir Shokrae, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter A. Fotinakes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven Schreiber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marylou V. Solbrig, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Vivek Jain, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gaby T. Thai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leif A. Havton, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Jeffrey R. Mora, MD |
|
|
Dr. Sarah Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janne K. Nissinen, MD |
|
|
Dr. Catherine Mamah, MD |